Scientists have made a major breakthrough in treating genetic deafness, as an experimental ear injection has successfully restored hearing in all 10 patients in a clinical trial.
In this study, researchers introduced a healthy version of a key hearing gene directly into the inner ear, which led to clear improvements in hearing within a few weeks. The treatment focuses on a rare inherited type of deafness caused by mutations in the OTOF gene, which plays an important role in sending sound signals from the ear to the brain. All ten participants, including young children and young adults, showed strong improvement in their hearing ability.
Most patients started reacting to sounds within a month, and many reached a level where they could clearly understand speech. The results also showed a big improvement in average hearing levels after the treatment, with younger patients showing even better progress, although adults and older children also experienced noticeable recovery.
Unlike hearing aids or cochlear implants that only help manage hearing loss, this gene therapy works on fixing the root genetic problem. Experts believe this could open the door to treating many other inherited hearing conditions in the future.
This progress is being seen as one of the most hopeful developments in restoring hearing and may help speed up finding cures for different types of genetic deafness.
